Value of Tissue Doppler Echocardiography in Predicting Response to Cardiac Resynchronization Therapy in Patients With Heart Failure
To access this article, please choose from the options below
Dr. Bax received grants from Medtronic, Minneapolis, Minnesota, Biotronik, Lake Oswego, Oregon, Boston Scientific, Natick, Massachusetts, BMS Medical Imaging, North Billerica, Massachusetts, St. Jude Medical, St. Paul, Minnesota, Edwards Life Sciences, Irvine, California, and GE Healthcare, St. Giles, United Kingdom. Dr. Schalij received grants from Biotronik, Lake Oswego, Oregon, Medtronic, Minneapolis, Minnesota, and Boston Scientific, Natick, Massachusetts.
PII: S0002-9149(09)02848-3
doi:10.1016/j.amjcard.2009.12.018
© 2010 Elsevier Inc. All rights reserved.
